Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1992 |  ESTA Establishment Labs Holdings Inc. - Common Shares | 69.33 USD | -1.85% | -4.87% | -26.84% | +39.61% | 2.07 B USD | ||
| 1994 |  PRGO Perrigo Company plc Ordinary Shares | 14.65 USD | +1.10% | +3.17% | +42.10% | -31.92% | 2.03 B USD | ||
| 1999 |  VCEL Vericel Corporation - Common Stock | 39.44 USD | -3.69% | -8.34% | -14.22% | +8.50% | 2.02 B USD | ||
| 2000 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.20 USD | -1.33% | -4.59% | +9.01% | +57.66% | 2.01 B USD | ||
| 2008 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.68 USD | +1.08% | +2.53% | +9.42% | -22.38% | 2.01 B USD | ||
| 2010 |  XNCR Xencor, Inc. - Common Stock | 27.27 USD | +4.64% | -5.97% | +36.62% | +235.01% | 2.03 B USD | ||
| 2012 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.64 USD | -0.52% | -10.96% | +15.76% | +219.67% | 1.98 B USD | ||
| 2017 |  NBTX Nanobiotix S.A. - ADSs | 40.64 USD | -1.43% | +1.27% | +8.17% | +390.23% | 1.97 B USD | ||
| 2018 |  PGNY Progyny, Inc. - Common Stock | 25.59 USD | -1.58% | +0.31% | -18.30% | +30.83% | 1.96 B USD | ||
| 2039 |  GENB Generate Biomedicines, Inc. - Common Stock | 14.92 USD | -2.67% | -13.21% | +5.67% | -0.53% | 1.92 B USD | ||
| 2046 |  CMPS COMPASS Pathways Plc - American Depository Shares | 13.51 USD | -1.60% | -6.18% | +20.41% | +112.09% | 1.87 B USD | ||
| 2050 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.32 USD | -0.82% | -0.49% | +7.46% | +8.48% | 1.87 B USD | ||
| 2055 |  LMAT LeMaitre Vascular, Inc. - Common Stock | 80.28 USD | -0.21% | +0.05% | -22.20% | -10.21% | 1.84 B USD | ||
| 2061 |  VIR Vir Biotechnology, Inc. - Common Stock | 10.94 USD | +1.02% | +9.07% | +25.17% | +82.94% | 1.85 B USD | ||
| 2064 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.68 USD | -1.56% | -4.86% | -3.57% | +95.86% | 1.85 B USD | ||
| 2070 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2072 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 122.74 USD | -0.54% | +22.74% | +49.94% | +52.32% | 1.81 B USD | ||
| 2074 |  INSP Inspire Medical Systems, Inc. Common Stock | 63.00 USD | +2.62% | +2.49% | +23.00% | -19.70% | 1.82 B USD | ||
| 2075 |  SNDA Sonida Senior Living, Inc. Common Stock | 37.52 USD | +0.03% | -5.99% | -7.88% | +48.95% | 1.80 B USD | ||
| 2076 |  BLFS BioLife Solutions, Inc. - Common Stock | 37.07 USD | +1.90% | -0.35% | +18.25% | +28.36% | 1.81 B USD |
Notizie Titoli del Settore Sanitario
Trump annuncia accordi sui prezzi dei farmaci con nove aziende
Lifeward nomina Josh Hexter CEO ad interim e Rami Aviram CFO
Teva annuncia un accordo con l’amministrazione Trump sui prezzi dei farmaci Medicaid
NeuroThera arruola 26 bambini in uno studio sul trattamento dell’autismo
Stryker acquisisce ZuriMED e il suo sistema per la riparazione della cuffia dei rotatori
Mizuho alza il target su BridgeBio Pharma a $110 grazie ad Attruby
Mizuho abbassa il target su Assembly Biosciences a $45
Gainers Titoli del Settore Sanitario
 VBIO Valion Bio, Inc. - Common stock | 3.57 | +2875.00% |
 NXL Nexalin Technology, Inc. - Common Stock | 7.23 | +2792.00% |
 GCTK GlucoTrack, Inc. - Common Stock | 4.25 | +1417.86% |
 ARTL Artelo Biosciences, Inc. - Common Stock | 6.36 | +863.64% |
 CALC CalciMedica, Inc. - Common Stock | 2.14 | +365.22% |
 RDHL Redhill Biopharma Ltd - American Depositary Shares | 0.90 | +36.36% |
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0552 | +26.90% |
 APLMW Apollomics Inc. - Warrant | 0.0139 | +24.11% |
Losers Titoli del Settore Sanitario
 BCAB BioAtla, Inc. - Common Stock | 1.74 | -44.59% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0004 | -42.86% |
 YDES YD Bio Limited - Ordinary Shares | 3.60 | -25.00% |
 TNONW Tenon Medical, Inc. - Warrant | 0.0074 | -24.49% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0101 | -21.71% |
 CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 6.69 | -20.92% |
 CINGW Cingulate Inc. - Warrants | 0.0062 | -20.51% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 3.40 | -18.66% |